Sangamo Therapeutics
SGMO
#10622
Rank
A$44.06 M
Marketcap
A$0.11
Share price
0.00%
Change (1 day)
-89.67%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2026 (TTM): -A$0.17 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are A$34.55 Million. In 2025 the company made an earning of -A$0.16 Billion a decrease over its 2024 earnings that were of -A$0.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.17 Billion5.88%
2025 -A$0.16 Billion9.71%
2024 -A$0.15 Billion-17.27%
2023 -A$0.18 Billion-40.88%
2022 -A$0.29 Billion9.79%
2021 -A$0.27 Billion41.52%
2020 -A$0.19 Billion23.17%
2019 -A$0.16 Billion36.33%
2018 -A$0.12 Billion36.89%
2017 -A$81.01 Million-22.32%
2016 -A$0.11 Billion54.86%
2015 -A$67.35 Million75.62%
2014 -A$38.35 Million0.13%
2013 -A$38.3 Million
2011 -A$51.49 Million43.66%
2010 -A$35.84 Million28.52%
2009 -A$27.89 Million-23.55%
2008 -A$36.48 Million2.45%
2007 -A$35.61 Million19.5%
2006 -A$29.8 Million50.78%
2005 -A$19.76 Million75%
2004 -A$11.3 Million-33.25%
2003 -A$16.92 Million-62.27%
2002 -A$44.84 Million102.82%
2001 -A$22.11 Million23.21%
2000 -A$17.95 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.66 B-23,855.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$14.78 B-9,424.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$1.45 B-1,016.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-A$1.44 Billion 803.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-A$2.81 Billion 1,672.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$11.05 B-7,070.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$1.61 B-1,119.42%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$0.21 B-235.16%๐Ÿ‡บ๐Ÿ‡ธ USA